Stokes Family Office’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $623K | Sell |
25,709
-45,423
| -64% | -$1.1M | 0.07% | 145 |
|
|
2025
Q1 | $1.8M | Buy |
71,132
+1
| +0% | +$25 | 0.2% | 89 |
|
|
2024
Q4 | $1.89M | Sell |
71,131
-4,779
| -6% | -$127K | 0.2% | 89 |
|
|
2024
Q3 | $2.2M | Buy |
75,910
+2,219
| +3% | +$64.2K | 0.24% | 76 |
|
|
2024
Q2 | $2.06M | Buy |
73,691
+466
| +0.6% | +$13K | 0.24% | 78 |
|
|
2024
Q1 | $2.03M | Sell |
73,225
-2,033
| -3% | -$56.4K | 0.25% | 81 |
|
|
2023
Q4 | $2.17M | Sell |
75,258
-17,429
| -19% | -$502K | 0.29% | 75 |
|
|
2023
Q3 | $3.07M | Sell |
92,687
-6,906
| -7% | -$229K | 0.36% | 68 |
|
|
2023
Q2 | $3.65M | Buy |
99,593
+1,337
| +1% | +$49K | 0.42% | 54 |
|
|
2023
Q1 | $4.01M | Sell |
98,256
-903
| -0.9% | -$36.8K | 0.5% | 46 |
|
|
2022
Q4 | $5.08M | Buy |
99,159
+1,170
| +1% | +$60K | 0.65% | 35 |
|
|
2022
Q3 | $4.29M | Sell |
97,989
-466
| -0.5% | -$20.4K | 0.61% | 36 |
|
|
2022
Q2 | $5.16M | Buy |
98,455
+1,181
| +1% | +$61.9K | 0.7% | 35 |
|
|
2022
Q1 | $5.04M | Sell |
97,274
-1,312
| -1% | -$67.9K | 0.67% | 36 |
|
|
2021
Q4 | $5.82M | Buy |
98,586
+2,589
| +3% | +$153K | 0.72% | 35 |
|
|
2021
Q3 | $4.13M | Buy |
95,997
+697
| +0.7% | +$30K | 0.57% | 46 |
|
|
2021
Q2 | $3.73M | Sell |
95,300
-1,052
| -1% | -$41.2K | 0.53% | 46 |
|
|
2021
Q1 | $3.49M | Sell |
96,352
-2,319
| -2% | -$84K | 0.54% | 47 |
|
|
2020
Q4 | $3.63M | Sell |
98,671
-2,992
| -3% | -$110K | 0.72% | 38 |
|
|
2020
Q3 | $3.54M | Buy |
101,663
+1,104
| +1% | +$38.4K | 0.8% | 35 |
|
|
2020
Q2 | $3.12M | Sell |
100,559
-1,049
| -1% | -$32.5K | 0.79% | 35 |
|
|
2020
Q1 | $3.15M | Buy |
101,608
+440
| +0.4% | +$13.6K | 0.84% | 30 |
|
|
2019
Q4 | $3.76M | Buy |
+101,168
| New | +$3.76M | 0.84% | 29 |
|